Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models
Schizophrenia is characterized by positive, negative and cognitive symptoms. All current antipsychotic treatments feature dopamine-receptor antagonism that is relatively effective at addressing the psychotic (positive) symptoms of schizophrenia. However, there is no clear evidence that these medicat...
Main Authors: | Kyna-Anne Conn, Thomas H. J. Burne, James P. Kesby |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2020.00542/full |
Similar Items
-
Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia
by: James P. Kesby, et al.
Published: (2013-07-01) -
Interaction of genotype and environment: Effect of strain and housing condition on cognitive behaviour in rodent models of schizophrenia
by: Karly M. Turner, et al.
Published: (2013-07-01) -
Baseline-dependent effects of amphetamine on attention are associated with striatal dopamine metabolism
by: Karly M. Turner, et al.
Published: (2017-03-01) -
Dopamine Health and Disease
Published: (2018) -
Diet, body weight and pain susceptibility – A systematic review of preclinical studies
by: Carolina Marques Miranda, et al.
Published: (2021-08-01)